John A. Ballantyne Revocable Living Trust dated 08/01/2017

CIK: 0002046615

Transaction Breakdown

Open Market Buys (P)3 (42.9%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GCTK

Glucotrack, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (7 total)

GCTK
Glucotrack, Inc.
Mar 12, 2025
In-the-Money(X)
Direct
2.6M shares-
GCTK
Glucotrack, Inc.
Nov 14, 2024
Award(A)
Series A Common Warrant
Direct
132K shares-
GCTK
Glucotrack, Inc.
Nov 14, 2024
Award(A)
Series B Common Warrant
Direct
132K shares-
GCTK
Glucotrack, Inc.
Nov 14, 2024
Other(J)
Direct
132K shares at avg. $31.00$4.1M
GCTK
Glucotrack, Inc.
Jul 30, 2024
Purchase(P)
Warrants to Purchase Common Stock
Direct
76.2K shares-
GCTK
Glucotrack, Inc.
Jul 30, 2024
Purchase(P)
Warrants to Purchase Common Stock
Direct
106.7K shares-
GCTK
Glucotrack, Inc.
Jul 30, 2024
Purchase(P)
Warrants to Purchase Common Stock
Direct
59.3K shares-

		Type	Shares	Price		Ownership
Mar 12, 2025	GCTK Glucotrack, Inc.	In-the-Money(X)	2,560,553	-	-	Direct
Nov 14, 2024	GCTK Glucotrack, Inc.	Award(A) Series A Common Warrant	132,036	-	-	Direct
Nov 14, 2024	GCTK Glucotrack, Inc.	Award(A) Series B Common Warrant	132,036	-	-	Direct
Nov 14, 2024	GCTK Glucotrack, Inc.	Other(J)	132,036	$31.00	$4,093,116	Direct
Jul 30, 2024	GCTK Glucotrack, Inc.	Purchase(P) Warrants to Purchase Common Stock	76,191	-	-	Direct
Jul 30, 2024	GCTK Glucotrack, Inc.	Purchase(P) Warrants to Purchase Common Stock	106,667	-	-	Direct
Jul 30, 2024	GCTK Glucotrack, Inc.	Purchase(P) Warrants to Purchase Common Stock	59,260	-	-	Direct

1-7 of 7 transactions

About John A. Ballantyne Revocable Living Trust dated 08/01/2017

John A. Ballantyne Revocable Living Trust dated 08/01/2017 (SEC CIK 0002046615) files insider reports with the SEC as 10% Owner of Glucotrack, Inc. (GCTK).

Signal8 holds 2 ownership filings by John A. Ballantyne Revocable Living Trust dated 08/01/2017 (1 Form 3, 1 Form 4), filed between Mar 28, 2025 and Mar 31, 2025. Those filings report 7 transactions, from Jul 30, 2024 to Mar 12, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on John A. Ballantyne Revocable Living Trust dated 08/01/2017's filings is in FARGO, ND.

Recent filings by John A. Ballantyne Revocable Living Trust dated 08/01/2017

Mar 12, 2025: Option exercise of GCTK shares (Form 4, code X).
Nov 14, 2024: Grants or awards of GCTK derivative securities (2 lines, Form 4, code A).
Nov 14, 2024: Other transaction of GCTK shares (Form 4, code J).
Jul 30, 2024: Open-market purchases of GCTK derivative securities (3 lines, Form 4, code P).

Other insiders filing for Glucotrack, Inc. (GCTK)

CARR BRENDEL VICTORIA, Director
Balo Andrew K, Director
Malave Luis, Director
Carter Erin Catherine, Director
Goode Paul, Chief Executive Officer
BALLANTYNE JOHN, Director

How to read Form 4 transaction codes